Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

Clinical trial NCT04160468 · TERMINATED

Trial details

NCT number: NCT04160468
Sponsor: ContraFect
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Staphylococcus Aureus Bacteremia Staphylococcus Aureus Endocarditis

Start date: 2019-12-20
Primary completion: 2022-09-09
Enrollment: 259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.